subject: UMLS:C0879250

object_name: HER2 positive breast carcinoma


subject: UMLS:C0879250

subject_name: HER-2-neu peptide vaccine

object_name: male breast carcinoma

tested_intervention: unsure


subject: UMLS:C0069515

subject_name: erbB-2 Receptor

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C0069515

object_name: Carcinoma breast stage IV


subject: UMLS:C0069515

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C0069515

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: MESH:C587878

object_name: B-cell chronic lymphocytic leukemia

tested_intervention: yes


subject: UNII:8375F9S90C

subject_name: Pamiparib

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UNII:8375F9S90C

object_name: malignant epithelial tumor of ovary


subject: UNII:8375F9S90C

object_name: primary peritoneal carcinoma


subject: UNII:8375F9S90C

object_name: Primary Peritoneal Cancer


subject: UNII:8375F9S90C

object_name: fallopian tube carcinosarcoma


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib


subject: UNII:B2K5L1L8S9

object_name: ovarian cancer


subject: UNII:B2K5L1L8S9

object_name: ovarian neoplasm


subject: UNII:B2K5L1L8S9

object_name: ovarian carcinoma


subject: UNII:B2K5L1L8S9


subject: UNII:B2K5L1L8S9


subject: UNII:B2K5L1L8S9


subject: UNII:B2K5L1L8S9


subject: CHEBI:60802

subject_name: ropivacaine

object_name: thoracic outlet syndrome


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: lupus nephritis


subject: PUBCHEM.COMPOUND:4240

subject_name: Mometasone furoate

object_name: asthma


subject: CHEBI:6970

subject_name: Mometasone


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: colon carcinoma


subject: PUBCHEM.COMPOUND:135659064

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:135659064

object_name: colon cancer


subject: UMLS:C0879272

object_name: renal carcinoma


subject: UMLS:C0879272

object_name: kidney neoplasm


subject: UMLS:C0879272

object_name: kidney cancer


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:52717


subject: CHEBI:52717


subject: UMLS:C5418072

subject_name: Anti-CD47 Monoclonal Antibody IMC-002

object_name: Advanced cancer


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: opioid use


subject: CHEBI:6121

subject_name: Ketamine

object_name: Postoperative Pain, Acute


subject: CHEBI:32599


subject: UMLS:C1711177

subject_name: Human Prostate-Specific Membrane Antigen Plasmid DNA Vaccine


subject: UMLS:C1711177


subject: UMLS:C1711177


subject: UMLS:C1709080

subject_name: Mouse Prostate-Specific Membrane Antigen Plasmid DNA Vaccine


subject: UMLS:C1709080


subject: UMLS:C1709080


subject: PUBCHEM.COMPOUND:74328238

subject_name: Sotagliflozin

object_name: Hepatic impairment


subject: CHEBI:4911

subject_name: Etoposide

object_name: non-small cell lung carcinoma


subject: GTOPDB:8088

subject_name: epratuzumab

object_name: acute lymphoblastic leukemia


subject: CHEMBL.COMPOUND:CHEMBL2108404

subject_name: EPRATUZUMAB


subject: UMLS:C0281743


subject: UMLS:C0879352

subject_name: Yttrium Y-90 Epratuzumab Tetraxetan


subject: UMLS:C2987594

object_name: type 2 diabetes mellitus


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Hodgkin Disease


subject: GTOPDB:9758

object_name: Adult Hodgkin Lymphoma


subject: GTOPDB:9758

object_name: Childhood Hodgkin Lymphoma


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Ovarian cancer stage IV


subject: UNII:2S9ZZM9Q9V

object_name: Ovarian cancer stage III


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Ovarian Cancer AJCC v8


subject: UMLS:C4547390

subject_name: Vigil vaccine

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C4547390


subject: UMLS:C4547390


subject: UMLS:C4547390


subject: UMLS:C4547390


subject: UMLS:C2916932

subject_name: Gammaplex

object_name: inborn error of immunity


subject: UMLS:C2916932

object_name: common variable immunodeficiency


subject: UMLS:C2916932

object_name: Acquired Hypogammaglobulinemia


subject: UMLS:C2916932

object_name: Bruton-type agammaglobulinemia


subject: UMLS:C2916932

object_name: Wiskott-Aldrich syndrome


subject: UMLS:C2916932

object_name: hyper-IgM syndrome


subject: UMLS:C2916932

object_name: hyper-IgM syndrome type 1


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: osteoarthritis, knee


subject: CHEBI:34967

subject_name: Rimonabant

object_name: type 2 diabetes mellitus


subject: UMLS:C4733690

subject_name: BTK Inhibitor ICP-022

object_name: marginal zone lymphoma


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: malignant tumor of nasopharynx


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: PUBCHEM.COMPOUND:10458325

subject_name: tesevatinib

object_name: autosomal dominant polycystic kidney disease


subject: CHEBI:167674

subject_name: Tesevatinib


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: severe traumatic brain injury


subject: CHEBI:39867

subject_name: Valproic acid


subject: UMLS:C5555615

subject_name: Anti-claudin18.2 Monoclonal Antibody ASKB589

object_name: Stomach cancer


subject: UMLS:C5555615

object_name: gastric cancer


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:85083

subject_name: Sofosbuvir

object_name: Adverse drug response


subject: PUBCHEM.COMPOUND:77335690

subject_name: Velpatasvir

object_name: chronic hepatitis C virus infection


subject: PUBCHEM.COMPOUND:77335690


subject: CHEBI:55352

subject_name: (R)-Atenolol

object_name: osteoporosis


subject: CHEBI:2904

subject_name: Atenolol


subject: CHEBI:64019

subject_name: Nebivolol


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:230837

subject_name: Dexanabinol

object_name: traumatic encephalopathy


subject: CHEBI:230837

object_name: traumatic brain injury


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:5281767

object_name: psychosis


subject: PUBCHEM.COMPOUND:5281767

object_name: Nonorganic psychosis


subject: PUBCHEM.COMPOUND:5281767

object_name: Psychosis, CTCAE


subject: CHEBI:10119

subject_name: Ziprasidone


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: Tinnitus


subject: UMLS:C0360094

object_name: Tinnitus, CTCAE 5.0


subject: UMLS:C0360094

object_name: Tinnitus, CTCAE 3.0


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Childhood Breast Carcinoma


subject: CHEBI:41423

object_name: breast cancer


subject: CHEBI:41423

object_name: breast neoplasm


subject: UMLS:C0004886

subject_name: BCG Vaccine

object_name: urinary bladder carcinoma


subject: UMLS:C0004886

object_name: urinary bladder cancer


subject: UMLS:C0004886

object_name: childhood bladder carcinoma


subject: CHEBI:41001

subject_name: Benzoylecgonine


subject: CHEBI:41001


subject: CHEBI:41001


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: PUBCHEM.COMPOUND:251912


subject: PUBCHEM.COMPOUND:251912


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: UMLS:C2698319


subject: UMLS:C2698319


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: PR:000002994


subject: PR:000002994


subject: CHEBI:176975

object_name: Solid Neoplasm


subject: CHEBI:65415

subject_name: Antroquinonol

object_name: hyperlipidemia


subject: UMLS:C5854383

subject_name: Long-acting Recombinant Erwinia asparaginase JZP-341

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5854383

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:9838675

subject_name: ARTEMISININ

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:9838675

object_name: schizoaffective disorder


subject: PUBCHEM.COMPOUND:9838675

object_name: schizophrenia 18


subject: MESH:D037621

subject_name: Artemisinins


subject: MESH:D037621


subject: MESH:D037621


subject: UMLS:C3887632

subject_name: human colostrum

object_name: Critical Illness


subject: UMLS:C3887632

object_name: infection as a complication


subject: UMLS:C3887632

object_name: multiple organ dysfunction syndrome


subject: UMLS:C0939935

subject_name: Colostrum Preparation


subject: UMLS:C0939935


subject: UMLS:C0939935


subject: CHEBI:232328

subject_name: Dordaviprone

object_name: Recurrent Endometrial Cancer


subject: UMLS:C3827072


subject: CHEBI:50861

subject_name: Treprostinil

object_name: Pulmonary arterial hypertension associated with portal hypertension


subject: DRUGBANK:DB10559

subject_name: Pistachio

object_name: Poor quality sleep


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Advanced Clear Cell Renal Cell Carcinoma


subject: UMLS:C3896806


subject: CHEBI:66910

subject_name: Axitinib


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:5383

subject_name: Glimepiride

object_name: diabetes mellitus


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: hepatitis C


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: UMLS:C0003234

subject_name: Anthracycline Antibiotics

object_name: Effects of chemotherapy


subject: CHEBI:49322

subject_name: anthracycline antibiotic


subject: CHEBI:48120

subject_name: anthracycline


subject: UNII:KXG2PJ551I

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:KXG2PJ551I

object_name: HER2 positive breast carcinoma


subject: UNII:KXG2PJ551I

object_name: estrogen-receptor positive breast cancer


subject: UNII:KXG2PJ551I

object_name: Locally advanced breast cancer


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:85993

object_name: triple-negative breast carcinoma


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: Abdominal Infection


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: CHEBI:43968

subject_name: Meropenem


subject: PUBCHEM.COMPOUND:155048066

subject_name: PRALURBACTAM


subject: DRUGBANK:DB19437

subject_name: Pralurbactam


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: Depressed mood


subject: CHEBI:53760

object_name: Cancer patients and suicide and depression


subject: CHEBI:53760

object_name: Depressed - symptom


subject: CHEBI:53760

object_name: Depression, CTCAE


subject: CHEBI:53760

object_name: sleep disorder, initiating and maintaining sleep


subject: UMLS:C2346810

object_name: non-small cell lung carcinoma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: blue rubber bleb nevus


subject: CHEBI:9168

object_name: Blue rubber bleb nevus syndrome


subject: CHEBI:9168

object_name: venous hemangioma


subject: CHEBI:9168

object_name: Venous malformation


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: rectal carcinoma


subject: UNII:15C2VL427D

object_name: rectal cancer


subject: UNII:15C2VL427D

object_name: Childhood Rectal Carcinoma


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: endogenous depression


subject: CHEBI:31236

object_name: major depressive disorder


subject: UMLS:C2986405

subject_name: PankoMab-GEX

object_name: primary peritoneal carcinoma


subject: UMLS:C2986405

object_name: Primary Peritoneal Cancer


subject: UMLS:C2986405

object_name: fallopian tube carcinoma


subject: UMLS:C2986405

object_name: fallopian tube cancer


subject: UMLS:C2986405

object_name: Recurrent ovarian cancer


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB

object_name: Metastatic Adult Malignant Neoplasm in the Brain


subject: UNII:DA64T2C2IO

object_name: Metastatic non-small cell lung cancer


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Presenile dementia


subject: CHEBI:36791

object_name: dementia


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:94534


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:8871


subject: UNII:VV3HN9ZPB5

subject_name: FOLLITROPIN ALFA

object_name: infertility


subject: UMLS:C4759807

subject_name: TSH, alpha Subunit


subject: MESH:D022242

subject_name: Pneumococcal Vaccines

object_name: Vaccine-Preventable Diseases


subject: UMLS:C5240157

subject_name: Vaccine product containing only Streptococcus pneumoniae antigen (medicinal product)


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba

object_name: Intrauterine growth restriction (IUGR)


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: CHEBI:63607

subject_name: Linezolid

object_name: pneumonia


subject: CHEBI:63607

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:28918

subject_name: Epinephrine

object_name: hypotension


subject: CHEBI:28918

object_name: Hypotension, CTCAE


subject: CHEBI:9123

subject_name: Sertraline

object_name: Cryptococcal meningitis


subject: CHEBI:9123

object_name: fungal meningitis


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: Light for dates


subject: UMLS:C3714803

object_name: fetal growth restriction


subject: UMLS:C3714803

object_name: Intracranial hemorrhage


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Sepsis


subject: CHEBI:25681

object_name: Sepsis, CTCAE


subject: UMLS:C0006669

subject_name: Calcitonin Gene-Related Peptide

object_name: migraine with aura


subject: PR:000014405

subject_name: protein S100-A12


subject: PUBCHEM.COMPOUND:71364

subject_name: icatibant

object_name: heart failure


subject: PUBCHEM.COMPOUND:71364

object_name: Heart Failure, CTCAE


subject: UMLS:C1522385

subject_name: Recombinant Gonadotropin

object_name: Encounter due to In vitro fertilization


subject: UMLS:C0018061

subject_name: Gonadotropins


subject: RXCUI:284885

subject_name: Tears Naturale Forte

object_name: dry eye syndrome


subject: RXCUI:284885

object_name: Dry Eye, CTCAE


subject: RXCUI:284885

object_name: Dryness of eye


subject: UMLS:C0939677

subject_name: Angiomax

object_name: Blood Clot


subject: UMLS:C0939677

object_name: thrombosis


subject: UMLS:C0939677

object_name: Thrombosis of blood vessel


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN


subject: CHEMBL.COMPOUND:CHEMBL5314348


subject: CHEMBL.COMPOUND:CHEMBL5314348


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: UMLS:C1314413


subject: UMLS:C1314413


subject: CHEBI:59173

subject_name: Bivalirudin


subject: CHEBI:59173


subject: CHEBI:59173


subject: CHEBI:71272

subject_name: Saxagliptin

object_name: Drug Interactions


subject: CHEBI:71272

object_name: Adverse drug interaction


subject: CHEBI:71272

object_name: Erectile dysfunction due to diabetes mellitus


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:9139


subject: CHEBI:9139

object_name: type 2 diabetes mellitus


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: focal segmental glomerulosclerosis


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: Psychosocial problem


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: scabies


subject: PUBCHEM.COMPOUND:6427057

object_name: Pediculus humanus capitis infestation


subject: CHEBI:6078

subject_name: Ivermectin


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Post-Operative Pain


subject: CHEBI:8378

object_name: post operative nausea and vomiting


subject: UNII:PT4P8MJP8L

subject_name: Tavapadon

object_name: Parkinson disease


subject: UMLS:C5139946


subject: UNII:N658GY6L3E

subject_name: Tebentafusp

object_name: uveal melanoma


subject: UMLS:C2986393


subject: UMLS:C0358855

object_name: Age-Related Memory Disorders


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: invasive breast carcinoma


subject: UNII:DPT0O3T46P

object_name: Her2-receptor negative breast cancer


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UMLS:C3640943


subject: PUBCHEM.COMPOUND:73680

object_name: influenza


subject: CHEBI:188074

object_name: endometriosis


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Vitamin D deficiency due to chronic kidney disease


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: PUBCHEM.COMPOUND:137706467

subject_name: Rimiducid

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:6539

subject_name: Lorazepam

object_name: Subfertility


subject: CHEBI:6539

object_name: infertility


subject: CHEBI:74538

subject_name: Leu-Gly-Gly

object_name: gastroenteritis


subject: UMLS:C0721277

subject_name: LGG brand of Dyphylline/Guaifenesin


subject: UMLS:C1832078

subject_name: LGG Lactobacillus rhamnosus GG


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Sepsis


subject: CHEBI:38290

object_name: Sepsis, CTCAE


subject: CHEBI:38290

object_name: metabolic disturbance


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: CHEBI:33283

subject_name: THIAMINE

object_name: septic shock


subject: CHEBI:33283


subject: CHEBI:33283


subject: CHEBI:33283


subject: CHEBI:18385

subject_name: Thiamine


subject: CHEBI:18385


subject: CHEBI:18385


subject: CHEBI:18385


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:91414

subject_name: Adavosertib

object_name: ovarian cancer


subject: CHEBI:91414

object_name: ovarian neoplasm


subject: CHEBI:91414

object_name: ovarian carcinoma


subject: CHEBI:91408

subject_name: Fedratinib


subject: CHEBI:91408

object_name: myelofibrosis


subject: CHEBI:91408

object_name: Post-polycythemia vera myelofibrosis


subject: DRUGBANK:DB14277

subject_name: Tripterygium wilfordii whole

object_name: IgA Nephropathy


subject: CHEBI:73666

subject_name: Thr-Trp


subject: UMLS:C2605865

object_name: cervical adenocarcinoma


subject: UMLS:C2605865

object_name: cervical squamous cell carcinoma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage IB Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:31355

object_name: stage IB non-small cell lung cancer


subject: CHEBI:31355

object_name: lung large cell carcinoma


subject: CHEBI:31355

object_name: squamous cell lung carcinoma


subject: CHEBI:31355

object_name: minimally invasive lung adenocarcinoma


subject: CHEBI:31355

object_name: adenosquamous lung carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:95067

subject_name: Iniparib


subject: UMLS:C1654827

subject_name: Apidra

object_name: type 1 diabetes mellitus


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: urothelial carcinoma


subject: UNII:5S371K6132

object_name: transitional cell carcinoma


subject: MESH:C000632490

object_name: Metastatic Renal Cell Carcinoma


subject: MESH:C000632490

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:87681

subject_name: Ranolazine

object_name: coronary microvascular disorder


subject: CHEBI:93772

subject_name: Ispinesib

object_name: Burkitt lymphoma


subject: CHEBI:93772

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:93772

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:93772

object_name: Recurrent Childhood Large Cell Lymphoma


subject: CHEBI:93772

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:93772

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:93772

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:93772

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: CHEBI:93772

object_name: recurrent childhood visual pathway and hypothalamic glioma


subject: CHEBI:93772

object_name: Recurrent Childhood Brain Neoplasm


subject: CHEBI:93772

object_name: childhood central nervous system germ cell tumor


subject: CHEBI:93772

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: CHEBI:93772

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: CHEBI:93772

object_name: pediatric infratentorial ependymoma


subject: CHEBI:93772

object_name: childhood choroid plexus neoplasm


subject: CHEBI:93772

object_name: Recurrent Childhood Brain Stem Glioma


subject: CHEBI:93772

object_name: Childhood Glioblastoma


subject: CHEBI:93772

object_name: childhood low-grade cerebral astrocytoma


subject: CHEBI:93772

object_name: pediatric supratentorial ependymoma


subject: CHEBI:93772

object_name: Recurrent Childhood Medulloblastoma


subject: CHEBI:93772

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:93772

object_name: childhood spinal cord tumor


subject: CHEBI:93772

object_name: Childhood Grade I Meningioma


subject: CHEBI:93772

object_name: Childhood Grade III Meningioma


subject: CHEBI:93772

object_name: Childhood Grade II Meningioma


subject: CHEBI:93772

object_name: Childhood Craniopharyngioma


subject: UMLS:C5139908

subject_name: Obexelimab

object_name: immunoglobulin G4-related sclerosing disease


subject: UMLS:C5139908

object_name: Immunoglobulin G4-Related Disease


subject: CHEBI:8871

subject_name: Risperidone

object_name: Alzheimer disease


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: metastatic prostate carcinoma


subject: UMLS:C5706502

subject_name: PRC2 Inhibitor ORIC-944


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: UNII:6DU9Y533FA

subject_name: VANADYL SULFATE

object_name: Prediabetes


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: invasive breast carcinoma


subject: CHEBI:233362

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:9CXQ3PF69U

subject_name: Imlunestrant


subject: UNII:9CXQ3PF69U


subject: UNII:9CXQ3PF69U


subject: UNII:9CXQ3PF69U


subject: CHEBI:51098

subject_name: Motesanib

object_name: myelofibrosis


subject: CHEMBL.COMPOUND:CHEMBL2107856

subject_name: IMETELSTAT


subject: PUBCHEM.COMPOUND:5339

subject_name: Sulfasalazine

object_name: sclerosing cholangitis


subject: PUBCHEM.COMPOUND:5339

object_name: primary sclerosing cholangitis


subject: CHEBI:31498

subject_name: Simethicone

object_name: Lesion of stomach


subject: CHEBI:4875

subject_name: Etanercept

object_name: Lumbosacral radiculopathy


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: UMLS:C0879624

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C3896762

object_name: Solid Neoplasm


subject: CHEBI:215747

subject_name: Tapinarof

object_name: psoriasis


subject: UNII:6897GXD6OE

object_name: cystic fibrosis


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: heart failure


subject: UMLS:C1450911

subject_name: TCH 346

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C1450911

object_name: amyotrophic lateral sclerosis


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: bariatric surgery candidate


subject: UMLS:C4086546

object_name: morbid obesity


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin


subject: PUBCHEM.COMPOUND:126456119

object_name: acute respiratory distress syndrome


subject: PUBCHEM.COMPOUND:126456119

object_name: adult acute respiratory distress syndrome


subject: PUBCHEM.COMPOUND:126456119

object_name: Middle East respiratory syndrome


subject: PUBCHEM.COMPOUND:126456119

object_name: Coronavinae infectious disease


subject: PR:000009978

subject_name: lactotransferrin


subject: PR:000009978


subject: PR:000009978


subject: PR:000009978


subject: PR:000009978


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UMLS:C0022942


subject: UMLS:C0022942


subject: UMLS:C0022942


subject: UMLS:C0022942


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: UniProtKB:Q8TCD2


subject: UniProtKB:Q8TCD2


subject: UniProtKB:Q8TCD2


subject: UniProtKB:Q8TCD2


subject: UMLS:C0052176

subject_name: apolactoferrin


subject: UMLS:C0052176


subject: UMLS:C0052176


subject: UMLS:C0052176


subject: UMLS:C0052176


subject: CHEBI:47426

subject_name: Furosemide

object_name: Delayed Graft Function


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UMLS:C0003442

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UMLS:C0003442

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: UMLS:C0003442

object_name: adult acute myeloid leukemia with del(5q)


subject: UMLS:C0003442

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: UMLS:C0003442

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: UMLS:C0003442

object_name: recurrent adult acute myeloid leukemia


subject: UMLS:C0003442

object_name: recurrent childhood acute myeloid leukemia


subject: UMLS:C0003442

object_name: Adult Acute Myeloid Leukemia in Remission


subject: UMLS:C0003442

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: UMLS:C0003442

object_name: Previously Treated Myelodysplastic Syndrome


subject: UMLS:C0003442

object_name: Blast Phase


subject: UMLS:C0003442

object_name: leukemia, myeloid, accelerated-phase


subject: UMLS:C0003442

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UMLS:C0003442


subject: UMLS:C0003442

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: UMLS:C0003442

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C0003442

object_name: De Novo Myelodysplastic Syndrome


subject: UMLS:C0003442

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:174615

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:174615

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:174615

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:174615

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:174615

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:174615

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:174615

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:174615

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:174615

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:174615

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:174615

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: CHEBI:174615

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:174615

object_name: Blast Phase


subject: CHEBI:174615

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:174615

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:174615


subject: CHEBI:174615

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:174615

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:174615

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:174615

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:28901

subject_name: Busulfan

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:28901

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:28901

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:28901

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:28901

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:28901

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:28901

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:28901

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:28901

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:28901

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:28901

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: CHEBI:28901

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:28901

object_name: Blast Phase


subject: CHEBI:28901

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:28901

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:28901


subject: CHEBI:28901

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:28901

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:28901

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:28901

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:93775

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:93775

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:93775

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:93775

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:93775

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:93775

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:93775

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:93775

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:93775

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: CHEBI:93775

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:93775

object_name: Blast Phase


subject: CHEBI:93775

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:93775

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:93775


subject: CHEBI:93775

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:93775

object_name: childhood myelodysplastic syndrome


subject: CHEBI:93775

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:93775

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:93775

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:50681

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:50681

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:50681

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:50681

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:50681

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:50681

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:50681

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:50681

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:50681

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:50681

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:50681

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: CHEBI:50681

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:50681

object_name: Blast Phase


subject: CHEBI:50681

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:50681

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:50681


subject: CHEBI:50681

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:50681

object_name: childhood myelodysplastic syndrome


subject: CHEBI:50681

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:50681

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:50681

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:44185

subject_name: Methotrexate

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:44185

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:44185

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:44185

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:44185

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:44185

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:44185

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:44185

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:44185

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:44185

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:44185

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: CHEBI:44185

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:44185

object_name: Blast Phase


subject: CHEBI:44185

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:44185

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:44185


subject: CHEBI:44185

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:44185

object_name: childhood myelodysplastic syndrome


subject: CHEBI:44185

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:44185

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:44185

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:61057

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:61057

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:61057

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:61057

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:61057

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:61057

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:61057

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:61057

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:61057

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: CHEBI:61057

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:61057

object_name: Blast Phase


subject: CHEBI:61057

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:61057

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:61057


subject: CHEBI:61057

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:61057

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:61057

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:61057

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:5372

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: PUBCHEM.COMPOUND:5372

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: PUBCHEM.COMPOUND:5372

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: PUBCHEM.COMPOUND:5372

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: PUBCHEM.COMPOUND:5372

object_name: adult acute myeloid leukemia with del(5q)


subject: PUBCHEM.COMPOUND:5372

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: PUBCHEM.COMPOUND:5372

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: PUBCHEM.COMPOUND:5372

object_name: recurrent adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:5372

object_name: recurrent childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:5372

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: PUBCHEM.COMPOUND:5372

object_name: Previously Treated Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:5372

object_name: Blast Phase


subject: PUBCHEM.COMPOUND:5372

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:5372

object_name: Leukemia, Myeloid, Chronic-Phase


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:5372

object_name: De Novo Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:5372

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:61049

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:61049

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:61049

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:61049

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:61049

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:61049

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:61049

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:61049

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:61049

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: CHEBI:61049

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:61049

object_name: Blast Phase


subject: CHEBI:61049

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:61049

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:61049


subject: CHEBI:61049

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:61049

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:61049

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:61049

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C5666896

subject_name: Anti-SARS-CoV-2 Hyperimmune Globulin CSL760


subject: CHEBI:32129

subject_name: diamminesilver(1+) fluoride

object_name: Arrested dental caries


subject: CHEBI:5613

subject_name: Haloperidol

object_name: Agitation, CTCAE 3.0


subject: CHEBI:5613

object_name: Agitation


subject: CHEBI:5613

object_name: Agitation, CTCAE 5.0


subject: CHEBI:132922

object_name: acute respiratory distress syndrome


subject: CHEBI:132922

object_name: adult acute respiratory distress syndrome


subject: CHEBI:132922

object_name: septic shock


subject: CHEBI:132922

object_name: lung disorder


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: kidney failure


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: Solid Neoplasm


subject: UMLS:C1512511

subject_name: Human Papilloma Virus Vaccine

object_name: chronic kidney disease


subject: UMLS:C1512511

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C5395272

subject_name: Vaccine product containing only Human papillomavirus antigen (medicinal product)


subject: UMLS:C5395272


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Metastatic leiomyosarcoma


subject: UNII:KXG2PJ551I

object_name: Liposarcoma metastatic


subject: UNII:KXG2PJ551I

object_name: Unresectable Leiomyosarcoma


subject: UNII:KXG2PJ551I

object_name: Unresectable Liposarcoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: chronic obstructive pulmonary disease


subject: UMLS:C3658854


subject: UMLS:C0304561

subject_name: rhubarb preparation

object_name: pneumonia


subject: UMLS:C0304561

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C0304561

object_name: Acute Stroke


subject: UMLS:C0304561

object_name: Acute Stroke Related to COVID-19


subject: DRUGBANK:DB10651

subject_name: Rhubarb


subject: DRUGBANK:DB10651


subject: DRUGBANK:DB10651


subject: DRUGBANK:DB10651


subject: UniProtKB:Q2EES9

subject_name: TORI_ECOLI Response regulator inhibitor for tor operon (sprot)

object_name: colorectal cancer


subject: UniProtKB:Q2EES9

object_name: colorectal carcinoma


subject: UniProtKB:Q2EES9

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UniProtKB:Q2EES9

object_name: Metastatic malignant neoplasm to liver


subject: UniProtKB:Q2EES9

object_name: Marinesco-Sjogren syndrome


subject: UniProtKB:Q2EES9

object_name: Microsatellite Stable


subject: PR:000024088

subject_name: response regulator inhibitor for tor operon


subject: PR:000024088


subject: PR:000024088


subject: PR:000024088


subject: PR:000024088


subject: PR:000024088


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: pain agnosia


subject: CHEBI:41879

object_name: Pain insensitivity


subject: PR:000004364

subject_name: achaete-scute homolog 3

object_name: Advanced Malignant Solid Neoplasm


subject: PR:000008202

subject_name: COP9 signalosome complex subunit 1


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: classic Kaposi sarcoma


subject: PUBCHEM.COMPOUND:3062

object_name: endemic Kaposi sarcoma


subject: PUBCHEM.COMPOUND:3062

object_name: Kaposi Sarcoma


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:4551


subject: CHEBI:4551


subject: CHEBI:6801

subject_name: Metformin

object_name: anovulation


subject: CHEBI:6801

object_name: Female infertility associated with anovulation


subject: UNII:1B8447E7YI

subject_name: CLOMIPHENE CITRATE


subject: UNII:1B8447E7YI


subject: UNII:1B8447E7YI

object_name: infertility


subject: UNII:1B8447E7YI

object_name: Androgen excess


subject: CHEBI:3752

subject_name: Clomifene


subject: CHEBI:3752


subject: CHEBI:3752


subject: CHEBI:3752


subject: CHEBI:68841

subject_name: Gadobutrol

object_name: Stage IB Cervical Cancer AJCC v8


subject: CHEBI:68841

object_name: stage IB cervical cancer


subject: CHEBI:68841

object_name: Stage IB Cervical Cancer AJCC v6 and v7


subject: CHEBI:68841

object_name: Stage IB2 Cervical Cancer AJCC v8


subject: CHEBI:68841

object_name: Stage IB2 Cervical Cancer


subject: CHEBI:68841

object_name: Stage IB1 Cervical Cancer AJCC v8


subject: CHEBI:68841

object_name: Stage IB1 Cervical Cancer


subject: CHEBI:68841

object_name: Stage IA1 Cervical Cancer AJCC v8


subject: CHEBI:68841

object_name: Stage IA1 Cervical Cancer


subject: CHEBI:68841

object_name: Stage IA Cervical Cancer AJCC v6 and v7


subject: CHEBI:68841

object_name: Stage IA Cervical Cancer AJCC v8


subject: CHEBI:68841

object_name: stage IA cervical cancer


subject: CHEBI:68841

object_name: Stage IA2 Cervical Cancer


subject: CHEBI:68841

object_name: Stage IA2 Cervical Cancer AJCC v8


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: rectal carcinoma


subject: UMLS:C5848866

object_name: rectal cancer


subject: UMLS:C5848866

object_name: Childhood Rectal Carcinoma


subject: DRUGBANK:DB16512

object_name: Metastatic Malignant Solid Neoplasm


subject: DRUGBANK:DB16512

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5198641

object_name: type 2 diabetes mellitus


subject: UMLS:C4282331

object_name: fragile X syndrome


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: arthropathy


subject: CHEBI:144903

object_name: osteoarthritis


subject: CHEBI:144903

object_name: Arthrosis


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: PR:000032963


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: alcohol abuse


subject: CHEBI:6887

object_name: alcohol dependence


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib

object_name: chronic graft versus host disease


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: UMLS:C5201181

subject_name: H.P. acthar gel

object_name: sarcoidosis


subject: UMLS:C5201181

object_name: sarcoidosis, susceptibility to, 1


subject: UMLS:C5201181

object_name: Hypercalcemia due to sarcoidosis


subject: PUBCHEM.COMPOUND:90488848


subject: PUBCHEM.COMPOUND:90488848


subject: PUBCHEM.COMPOUND:90488848


subject: CHEBI:3892

subject_name: Corticotropin


subject: CHEBI:3892


subject: CHEBI:3892


subject: UMLS:C0718234

subject_name: Acthar


subject: UMLS:C0718234


subject: UMLS:C0718234


subject: UMLS:C2825093

subject_name: Adrenocorticotropic Hormone [EPC]


subject: UMLS:C2825093


subject: UMLS:C2825093


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: primary brain neoplasm


subject: CHEBI:4026

object_name: brain cancer


subject: CHEBI:4026

object_name: medulloblastoma


subject: CHEBI:4026

object_name: childhood medulloblastoma


subject: CHEBI:4026

object_name: adult medulloblastoma


subject: CHEBI:4026

object_name: glioma susceptibility 1


subject: CHEBI:4026

object_name: ependymoma


subject: CHEBI:4026

object_name: childhood ependymoma


subject: CHEBI:4026

object_name: Newly Diagnosed Childhood Ependymoma


subject: CHEBI:4026

object_name: Adult Ependymoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911

object_name: glioblastoma


subject: CHEBI:4911

object_name: Childhood Glioblastoma


subject: CHEBI:4911

object_name: adult glioblastoma


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:91397

subject_name: Ibrutinib


subject: CHEBI:91397


subject: CHEBI:91397


subject: CHEBI:91397


subject: CHEBI:91397


subject: CHEBI:91397


subject: CHEBI:91397


subject: CHEBI:91397


subject: CHEBI:91397


subject: CHEBI:91397


subject: CHEBI:91397


subject: CHEBI:91397


subject: CHEBI:91397


subject: CHEBI:230682

subject_name: Indoximod


subject: CHEBI:230682


subject: CHEBI:230682


subject: CHEBI:230682


subject: CHEBI:230682


subject: CHEBI:230682


subject: CHEBI:230682


subject: CHEBI:230682


subject: CHEBI:230682


subject: CHEBI:230682


subject: CHEBI:230682


subject: CHEBI:230682


subject: CHEBI:230682


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: PUBCHEM.COMPOUND:56841751

subject_name: Epidermal Growth Factor

object_name: Deep partial thickness burn


subject: PR:000006928

subject_name: pre-pro-epidermal growth factor


subject: PR:000060269

subject_name: epidermal growth factor


subject: CHEBI:9142

subject_name: Silver sulfadiazine


subject: CHEBI:50378

subject_name: Nitisinone

object_name: albinism


subject: CHEBI:50378

object_name: blindness


subject: CHEBI:50378

object_name: Visual loss


subject: CHEBI:50378

object_name: Loss of Vision


subject: CHEBI:50378

object_name: Impaired Vision


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: thyroid tumor


subject: UNII:5S371K6132

object_name: Embolism, Tumor


subject: UNII:5S371K6132

object_name: Neoplasm Metastasis


subject: UNII:5S371K6132

object_name: Metastasis


subject: UNII:5S371K6132

object_name: Metastatic Lesion


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: ADHF


subject: CHEBI:6456

subject_name: Lidocaine

object_name: macular degeneration


subject: CHEBI:6456

object_name: age-related macular degeneration


subject: CHEBI:6456

object_name: retinitis pigmentosa 30


subject: CHEBI:8485

subject_name: Proparacaine


subject: CHEBI:8485


subject: CHEBI:8485


subject: CHEBI:9468

subject_name: Tetracaine


subject: CHEBI:9468


subject: CHEBI:9468


subject: UMLS:C4733605

object_name: Adult Solid Neoplasm


subject: UMLS:C4733605

object_name: pancreatic neoplasm


subject: UMLS:C4733605

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4733605

object_name: malignant pancreatic neoplasm


subject: UMLS:C4733605

object_name: ovarian cancer


subject: UMLS:C4733605

object_name: ovarian neoplasm


subject: UMLS:C4733605

object_name: ovarian carcinoma


subject: UMLS:C4733605

object_name: Childhood Breast Carcinoma


subject: UMLS:C4733605

object_name: breast carcinoma


subject: UMLS:C4733605

object_name: breast cancer


subject: CHEBI:18290

subject_name: COCARBOXYLASE

object_name: type 2 diabetes mellitus


subject: CHEBI:18385

subject_name: Thiamine


subject: CHEBI:4911

object_name: childhood acute myeloid leukemia


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:6704

subject_name: Mebendazole

object_name: helminthiasis


subject: UMLS:C1449659

subject_name: 4-Aminopyridine Sustained Release

object_name: multiple sclerosis


subject: CHEBI:95341

subject_name: Baricitinib

object_name: juvenile idiopathic arthritis


subject: PUBCHEM.COMPOUND:134612761

subject_name: macimorelin

object_name: Malignant cachexia


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Locally advanced breast cancer


subject: MESH:C520255

object_name: Unresectable Breast Carcinoma


subject: MESH:C520255

object_name: CD274 Gene Mutation


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UMLS:C5400891


subject: CHEBI:233453

object_name: prostate carcinoma


subject: CHEBI:233453

object_name: prostate cancer


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:35854


subject: UNII:G9WJT6RD29

subject_name: Burosumab

object_name: Nevus sebaceous


subject: UMLS:C3896830


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: ankylosing spondylitis


subject: PUBCHEM.COMPOUND:25110515

subject_name: Ozanimod


subject: CHEBI:231324

subject_name: alpelisib

object_name: Advanced breast cancer


subject: CHEBI:32599

object_name: Mesothelioma


subject: CHEBI:32599

object_name: mesothelial neoplasm


subject: CHEBI:32599

object_name: malignant mesothelioma


subject: CHEBI:6121

subject_name: Ketamine

object_name: Fusion of spine (disease)


subject: CHEBI:6121

object_name: spinal stenosis


subject: CHEBI:6121

object_name: Spinal Neoplasm


subject: CHEBI:6121

object_name: Spine tumor


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: Dysuria


subject: CHEBI:9398

object_name: Dysuria, CTCAE


subject: CHEBI:9398

object_name: multiple sclerosis


subject: CHEBI:9398

object_name: Dysfunctional voiding of urine


subject: UMLS:C3850285

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:138376495

subject_name: Cefiderocol

object_name: gram-negative bacterial infections


subject: PUBCHEM.COMPOUND:138376495

object_name: Sepsis


subject: PUBCHEM.COMPOUND:138376495

object_name: Sepsis, CTCAE


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: female reproductive system disorder


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: common cold


subject: CHEBI:27732

subject_name: Caffeine


subject: UMLS:C5565852

subject_name: cabotegravir extended-release injectable suspension

object_name: Prevention problem


subject: CHEBI:64816

object_name: triple-negative breast carcinoma


subject: CHEBI:64816

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: MESH:C000612945

subject_name: colla corii asini

object_name: Pregnant


subject: MESH:C000612945

object_name: thalassemia


subject: UMLS:C2986991

subject_name: VEGFR2-targeted Contrast Agent BR55

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:135515

subject_name: Bendamustine

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:135515

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:135515

object_name: primary cutaneous lymphoma


subject: CHEBI:135515

object_name: Cutaneous lymphoma


subject: CHEBI:135515

object_name: lymphomatoid papulosis


subject: CHEBI:135515

object_name: lymphoproliferative syndrome


subject: CHEBI:135515

object_name: mycosis fungoides


subject: CHEBI:135515

object_name: Sezary syndrome


subject: CHEBI:135515

object_name: neoplasm


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: B-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: liver neoplasm


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UNII:92E9B7675Y

object_name: chronic obstructive pulmonary disease


subject: UNII:92E9B7675Y

object_name: pulmonary hypertension


subject: UNII:92E9B7675Y

object_name: Pulmonary Hypertension, CTCAE


subject: UNII:82SK298EBU


subject: UNII:82SK298EBU


subject: UNII:82SK298EBU


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: aortic valve disorder


subject: CHEBI:32129

subject_name: diamminesilver(1+) fluoride

object_name: Caries (morphologic abnormality)


subject: UMLS:C4289938

subject_name: Balanced Crystalloid Solution

object_name: brain cancer


subject: UMLS:C4289938

object_name: brain neoplasm


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: PUBCHEM.COMPOUND:23664049

subject_name: SODIUM GLUCONATE


subject: PUBCHEM.COMPOUND:23664049


subject: CHEBI:33198

subject_name: Gluconic Acid


subject: CHEBI:33198


subject: CHEBI:32138

subject_name: SODIUM ACETATE


subject: CHEBI:32138


subject: CHEBI:32588

subject_name: Potassium chloride


subject: CHEBI:32588


subject: CHEBI:86345

subject_name: magnesium dichloride hexahydrate


subject: CHEBI:86345


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:149509

object_name: mitral valve insufficiency


subject: CHEBI:3347

subject_name: Candesartan


subject: UNII:A14FB57V1D

subject_name: GLYCOPYRRONIUM

object_name: asthma


subject: UNII:3H8GSZ4SQL

subject_name: Avatrombopag

object_name: Drug action (disorder)


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: HER2 positive breast carcinoma


subject: CHEBI:114785

subject_name: Erlotinib

object_name: fallopian tube carcinoma


subject: CHEBI:114785

object_name: fallopian tube cancer


subject: CHEBI:114785

object_name: ovarian cancer


subject: CHEBI:114785

object_name: ovarian neoplasm


subject: CHEBI:114785

object_name: ovarian carcinoma


subject: CHEBI:114785

object_name: peritoneum cancer


subject: CHEBI:24848

subject_name: inositol

object_name: gestational diabetes


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: Helicobacter pylori gastrointestinal tract infection


subject: PUBCHEM.COMPOUND:9800288

subject_name: METOPROLOL SUCCINATE


subject: CHEBI:6904

subject_name: Metoprolol


subject: UMLS:C0723783

subject_name: Toprol-XL


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:7903

subject_name: Pamidronic acid

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:7903

object_name: Back pain


subject: CHEBI:7903

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:7903

object_name: Low back pain


subject: CHEBI:7903

object_name: intervertebral disk degenerative disorder


subject: CHEBI:40279

subject_name: Allopurinol

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: CHEBI:174615

object_name: severe combined immunodeficiency


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:90865

subject_name: Flibanserin

object_name: hypoactive sexual desire disorder


subject: GTOPDB:4985

object_name: metastatic melanoma


subject: GTOPDB:4985

object_name: Metastatic Renal Cell Carcinoma


subject: GTOPDB:4985

object_name: Metastatic Renal Cell Cancer


subject: GTOPDB:4985

object_name: head and neck squamous cell carcinoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: pancreatic neoplasm


subject: CHEBI:5801

object_name: exocrine pancreatic carcinoma


subject: CHEBI:5801

object_name: malignant pancreatic neoplasm


subject: CHEBI:5801

object_name: Advanced cancer


subject: UNII:V0Q46LFE6F


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Cervical myelopathy


subject: PUBCHEM.COMPOUND:9824461

object_name: ossification of the posterior longitudinal ligament of the spine


subject: CHEBI:23965

subject_name: estradiol

object_name: anovulation


subject: CHEBI:23965

object_name: Female infertility associated with anovulation


subject: CHEBI:23965

object_name: infertility


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: Acne inversa


subject: CHEBI:6801

subject_name: Metformin

object_name: Frailty


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: Transformed migraine


subject: CHEBI:31652

subject_name: Gimeracil

object_name: Stomach cancer


subject: CHEBI:31652

object_name: gastric cancer


subject: MESH:C414006

subject_name: 23-valent pneumococcal capsular polysaccharide vaccine

object_name: meningitis


subject: MESH:C414006

object_name: Meningitis, CTCAE


subject: RXCUI:287523

subject_name: Pneumovax 23


subject: RXCUI:287523


subject: UNII:C9R35M8XV6

subject_name: Hiberix


subject: UNII:C9R35M8XV6


subject: UNII:8GZG754X6M

subject_name: Gemtuzumab

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0677800

subject_name: CMA 676


subject: CHEBI:139608

subject_name: sepantronium bromide

object_name: high grade B-cell lymphoma


subject: CHEBI:139608

object_name: High Grade Lymphoma


subject: CHEBI:139608

object_name: B-cell neoplasm


subject: CHEBI:139608

object_name: C-MYC/BCL6 double-hit high-grade B-cell lymphoma


subject: CHEBI:139608

object_name: C-MYC/BCL2 double-hit high-grade B-cell lymphoma


subject: CHEBI:139608

object_name: Burkitt lymphoma


subject: CHEBI:139608

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:139608

object_name: Adult Burkitt Lymphoma


subject: CHEBI:139608

object_name: MYC Gene Rearrangement


subject: CHEBI:139608

object_name: diffuse large B-cell lymphoma


subject: CHEBI:139608

object_name: lymphoid system disorder


subject: CHEBI:139608

object_name: Lymphadenopathy


subject: UMLS:C2980068


subject: UMLS:C2980068


subject: UMLS:C2980068


subject: UMLS:C2980068


subject: UMLS:C2980068


subject: UMLS:C2980068


subject: UMLS:C2980068


subject: UMLS:C2980068


subject: UMLS:C2980068


subject: UMLS:C2980068


subject: UMLS:C2980068


subject: UMLS:C2980068


subject: UMLS:C4287773

subject_name: VLP-encapsulated TLR9 Agonist CMP-001

object_name: melanoma


subject: PUBCHEM.COMPOUND:136170999

subject_name: FOLFIRI regimen

object_name: cancer


subject: PUBCHEM.COMPOUND:136170999

object_name: diarrhea


subject: PUBCHEM.COMPOUND:136170999

object_name: rectal discharge diarrhea (physical finding)


subject: PUBCHEM.COMPOUND:136170999

object_name: Diarrhea, CTCAE


subject: MESH:C461320

subject_name: shosaiko-to


subject: MESH:C461320


subject: MESH:C461320


subject: MESH:C461320


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:146624881

subject_name: DIVARASIB


subject: UNII:E6S21PVT91


subject: CHEBI:195558

subject_name: Entrectinib


subject: CHEBI:63637

subject_name: Vemurafenib


subject: GTOPDB:4985

object_name: HIV infection


subject: GTOPDB:4985

object_name: AIDS


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: CHEBI:74947

subject_name: Thalidomide


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: endometrial cancer


subject: UNII:P0GVQ9A4S5

object_name: uterine corpus cancer


subject: UNII:P0GVQ9A4S5

object_name: endometrial carcinoma


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin


subject: UNII:2CN60TN6ZS


subject: CHEBI:3139

subject_name: bleomycin

object_name: lymphatic malformation


subject: CHEBI:3139

object_name: Congenital lymphatic malformation


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Fused vertebrae


subject: CHEBI:41879

object_name: spinal stenosis


subject: CHEBI:41879

object_name: spinal disease


subject: UMLS:C5203471

subject_name: Dexmedetomidine Liquid Injection


subject: UMLS:C5203471


subject: UMLS:C5203471


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: CHEBI:4466


subject: UMLS:C3714111

object_name: urinary bladder carcinoma


subject: UMLS:C3714111

object_name: colorectal adenocarcinoma


subject: UMLS:C3714111

object_name: breast carcinoma


subject: KEGG.COMPOUND:C02380

object_name: complete trisomy 21


subject: KEGG.COMPOUND:C02380

object_name: Down syndrome


subject: KEGG.COMPOUND:C02380

object_name: childhood malignant neoplasm


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:64677


subject: CHEBI:64677


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: CHEBI:41977


subject: UMLS:C3255308

subject_name: l-asparaginase (E.Coli)


subject: UMLS:C3255308


subject: UMLS:C3255308

object_name: acute lymphoblastic leukemia


subject: UMLS:C3255308


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: GTOPDB:5962

subject_name: dovitinib

object_name: pancreatic neoplasm


subject: GTOPDB:5962

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:5962

object_name: malignant pancreatic neoplasm


subject: GTOPDB:5962

object_name: colorectal cancer


subject: GTOPDB:5962

object_name: colorectal carcinoma


subject: GTOPDB:5962

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4308663

subject_name: IDegLira

object_name: type 2 diabetes mellitus


subject: UMLS:C5417892

subject_name: Oncolytic Type 2 Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor OH2

object_name: Advanced Colorectal Carcinoma


subject: CHEBI:76777

subject_name: poly(inosinic acid)

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: PUBCHEM.COMPOUND:135537060

subject_name: Rintatolimod


subject: UNII:94325AJ25N

subject_name: RINTATOLIMOD


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Night Eating Syndrome


subject: CHEBI:3723

subject_name: Citalopram


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: brain neoplasm


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: CHEBI:64312

subject_name: Memantine

object_name: Childhood Breast Carcinoma


subject: CHEBI:64312

object_name: breast carcinoma


subject: CHEBI:64312

object_name: breast cancer


subject: CHEBI:64312

object_name: Cognitive impairment


subject: CHEBI:64312

object_name: Mental deterioration


subject: CHEBI:64312

object_name: Breast cancer stage III


subject: CHEBI:64312

object_name: Breast cancer stage II


subject: CHEBI:64312

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:64312

object_name: malignant neoplasm of breast stage I


subject: CHEBI:64312

object_name: Carcinoma breast stage I


subject: CHEBI:64312

object_name: Cognitive changes


subject: CHEBI:64312

object_name: Locally advanced breast cancer


subject: UNII:DY6W3NQA36

object_name: Huntington disease


subject: UMLS:C4763656

subject_name: Adenosine A2A Receptor Antagonist/Phosphodiesterase 10A PBF-999


subject: UMLS:C5555866

subject_name: FR Alpha/TRPV6 Bispecific Ligand Drug Conjugate CBP-1008

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:134856

subject_name: Creatinolfosfate

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: PR:000005036

subject_name: caspase recruitment domain-containing protein 16


subject: UMLS:C5203275

subject_name: Pralatrexate Liquid Injection


subject: UMLS:C2959279

subject_name: Injection, pralatrexate, 1 mg


subject: CHEBI:94531

subject_name: belinostat


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: soft tissue sarcoma


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: prostate cancer


subject: UNII:DPT0O3T46P

object_name: prostate neoplasm


subject: UMLS:C4547431

subject_name: NeuroBloc

object_name: Hyperhidrosis, CTCAE


subject: UMLS:C4547431

object_name: Hyperhidrosis


subject: UNII:0Y70779M1F

subject_name: Botulinum toxin type B


subject: UNII:0Y70779M1F


subject: CHEMBL.COMPOUND:CHEMBL1201569

subject_name: RIMABOTULINUMTOXINB


subject: CHEMBL.COMPOUND:CHEMBL1201569


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Pain in female genitalia on intercourse


subject: CHEBI:60789

object_name: Dyspareunia


subject: CHEBI:60789

object_name: Dyspareunia, CTCAE


subject: CHEBI:60789

object_name: Painful intercourse female


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:85990

subject_name: Panobinostat

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:85990

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:85990

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:85990

object_name: anaplastic large cell lymphoma


subject: CHEBI:85990

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:85990

object_name: small intestine lymphoma


subject: CHEBI:85990

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:85990

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:85990

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:85990

object_name: splenic marginal zone lymphoma


subject: CHEBI:85990

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:85990

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:85990

object_name: MALT lymphoma


subject: CHEBI:85990

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:85990

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:85990

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:85990

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:85990


subject: CHEBI:85990

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:85990

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C1446440

subject_name: Cupressus arizonica antigen

object_name: Allergy to tree pollen


subject: CHEBI:132082

subject_name: Entinostat

object_name: Locally Advanced Breast Carcinoma


subject: CHEBI:132082

object_name: Breast cancer recurrent


subject: CHEBI:132082

object_name: Metastatic Breast Carcinoma


subject: CHEBI:132082

object_name: HER2/Neu Negative


subject: PR:000037023

subject_name: influenzavirus M gene translation product

object_name: influenza


subject: PR:000037023

object_name: Infection following immunization


subject: UMLS:C1174887

object_name: Sepsis


subject: UMLS:C1174887

object_name: Sepsis, CTCAE


subject: UMLS:C1174887

object_name: Disseminated Intravascular Coagulation Related to COVID-19


subject: UMLS:C1174887

object_name: disseminated intravascular coagulation


subject: UMLS:C1174887

object_name: Disseminated Intravascular Coagulation, CTCAE


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Advanced Pancreatic Ductal Adenocarcinoma


subject: UNII:PQX0D8J21J

object_name: Advanced Esophageal Adenocarcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: endometrial cancer


subject: CHEBI:6715

object_name: endometrial carcinoma


subject: UMLS:C1831604

object_name: liver carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108758

subject_name: PEPPERMINT OIL

object_name: colonic disease


subject: CHEMBL.COMPOUND:CHEMBL2108758

object_name: Visceral Pain


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Arthralgia


subject: PUBCHEM.COMPOUND:521372

object_name: Arthralgia, CTCAE


subject: PUBCHEM.COMPOUND:521372

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:521372

object_name: breast cancer


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: CHEBI:39585


subject: CHEBI:39585

object_name: breast carcinoma


subject: CHEBI:39585


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: type 2 diabetes mellitus


subject: UMLS:C2718754

subject_name: Ilaris


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: bone giant cell tumor


subject: UMLS:C1530450

subject_name: AMG 162


subject: UNII:997WVV895X

subject_name: Rimegepant

object_name: migraine


subject: UNII:997WVV895X

object_name: migraine with or without aura, susceptibility to, 1


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone

object_name: heart failure


subject: CHEBI:32020

subject_name: Pitavastatin


subject: CHEBI:63660


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:135720

subject_name: Deflazacort

object_name: kidney failure


subject: UNII:85KUE857XM

subject_name: SHR-1258 dimaleate

object_name: Childhood Solid Neoplasm


subject: UNII:85KUE857XM

object_name: Adult Solid Neoplasm


subject: UNII:85KUE857XM

object_name: Solid Neoplasm


subject: UMLS:C5206643

subject_name: Pyrotinib Dimaleate


subject: UMLS:C5206643


subject: UMLS:C5206643


subject: CHEBI:63613

subject_name: Nevirapine

object_name: Hypercholesterolemia


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: colorectal cancer


subject: CHEBI:41879

object_name: colorectal carcinoma


subject: CHEBI:41879

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:41879

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:41879

object_name: Embolism, Tumor


subject: CHEBI:41879

object_name: Neoplasm Metastasis


subject: CHEBI:193615


subject: CHEBI:193615


subject: CHEBI:193615


subject: CHEBI:193615


subject: CHEBI:193615


subject: CHEBI:193615


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:60761


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: UMLS:C4725103

subject_name: mTORC 1/2 Inhibitor LXI-15029

object_name: Advanced breast cancer


subject: CHEBI:4953

subject_name: Exemestane


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:231005

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:231005

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:5931

subject_name: insulin human

object_name: cystic fibrosis


subject: CHEBI:5931

object_name: glucose metabolism disease


subject: UMLS:C0876064

subject_name: Lantus


subject: UMLS:C0876064


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: spondylolisthesis


subject: PUBCHEM.COMPOUND:4715169

object_name: Congenital spondylolisthesis


subject: PUBCHEM.COMPOUND:4715169

object_name: Acquired spondylolisthesis


subject: PUBCHEM.COMPOUND:4715169

object_name: Congenital postural scoliosis


subject: PUBCHEM.COMPOUND:4715169

object_name: scoliosis


subject: PUBCHEM.COMPOUND:4715169

object_name: Scoliosis, CTCAE


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:64356


subject: UMLS:C2930158

subject_name: WITHANIA SOMNIFERA

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C2930158

object_name: obesity


subject: UMLS:C2930158

object_name: Obesity, CTCAE


subject: UMLS:C2930158

object_name: Overweight


subject: CHEBI:233197

subject_name: devimistat

object_name: cancer


subject: CHEBI:233197

object_name: neoplasm


subject: CHEBI:233197

object_name: exocrine pancreatic carcinoma


subject: CHEBI:233197

object_name: pancreatic neoplasm


subject: CHEBI:233197

object_name: malignant pancreatic neoplasm


subject: UMLS:C2703200

subject_name: CPI 613


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: CHEBI:45267

subject_name: praziquantel

object_name: intestinal schistosomiasis


subject: CHEBI:45267

object_name: Schistosoma mansoni infectious disease


subject: CHEBI:45267

object_name: Katayama Fever


subject: CHEBI:91583

subject_name: Praziquantel


subject: CHEBI:91583


subject: CHEBI:91583


subject: CHEBI:45783

subject_name: Imatinib

object_name: disseminated eosinophilic collagen disease


subject: CHEBI:45783

object_name: Eosinophilia


subject: CHEBI:45783

object_name: idiopathic hypereosinophilic syndrome


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:93775

subject_name: Amethopterin

object_name: inflammatory bowel disease


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UNII:4W3KFI3TN3

subject_name: Talquetamab

object_name: Extramedullary Disease in Plasma Cell Myeloma


subject: UMLS:C4687984

subject_name: talquetamab


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Temporomandibular joint disc displacement, with reduction


subject: CHEBI:44915

subject_name: Propofol

object_name: Disease Progression


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:6950

subject_name: Mirtazapine


subject: CHEBI:6950


subject: CHEBI:6950

object_name: Neoplasm Metastasis


subject: CHEBI:231683

subject_name: Anakinra

object_name: Sepsis


subject: CHEBI:231683

object_name: Sepsis, CTCAE


subject: CHEBI:231683

object_name: macrophage activation syndrome


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: PR:000001137


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: cervical cancer


subject: UMLS:C1527149

subject_name: Recombinant 70-kD Heat-Shock Protein

object_name: leukemia


subject: UMLS:C1527149

object_name: childhood leukemia


subject: UMLS:C0243043

subject_name: Heat-Shock Proteins 70


subject: UMLS:C0243043


subject: PUBCHEM.COMPOUND:4568

subject_name: Nystatin A1

object_name: oral candidiasis


subject: PUBCHEM.COMPOUND:4568

object_name: HIV infection


subject: CHEMBL.COMPOUND:CHEMBL5465559

subject_name: NYSTATIN


subject: CHEMBL.COMPOUND:CHEMBL5465559


subject: CHEBI:7660

subject_name: nystatin


subject: CHEBI:7660


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: ischemic attack


subject: CHEBI:37941

object_name: brain ischemia


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: cystic fibrosis


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:37941

object_name: Neck Carcinoma


subject: CHEBI:37941

object_name: head and neck neoplasm


subject: CHEBI:37941

object_name: head and neck cancer


subject: CHEBI:135207

subject_name: Clofedanol


subject: CHEBI:135207


subject: CHEBI:135207


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:15365


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: nonpapillary renal cell carcinoma


subject: UNII:GKF8S4C432

object_name: clear cell renal carcinoma


subject: UNII:GKF8S4C432

object_name: renal cell adenocarcinoma


subject: UNII:GKF8S4C432

object_name: renal cell carcinoma


subject: CHEBI:173763

subject_name: Thermophillin


subject: CHEBI:173763

object_name: substance abuse


subject: PUBCHEM.COMPOUND:23597337

subject_name: Physalin L


subject: PUBCHEM.COMPOUND:23597337


subject: CHEBI:4659

subject_name: Disulfiram


subject: CHEBI:4659


subject: CHEBI:37924

subject_name: Atazanavir


subject: CHEBI:119486

subject_name: Efavirenz


subject: CHEBI:45409

subject_name: Ritonavir


subject: UMLS:C4287711

subject_name: METAP2 inhibitor SDX-7320

object_name: Embolism, Tumor


subject: UMLS:C4287711

object_name: Neoplasm Metastasis


subject: UMLS:C4287711

object_name: Metastasis


subject: UMLS:C4287711

object_name: Metastatic Lesion


subject: UMLS:C4287711

object_name: childhood neoplasm


subject: UMLS:C4287711

object_name: neoplastic syndrome


subject: UMLS:C4287711

object_name: cancer or benign tumor


subject: UMLS:C4287711

object_name: neoplasm


subject: CHEBI:32127

subject_name: sevelamer

object_name: Heart valve calcification


subject: CHEMBL.COMPOUND:CHEMBL5314349

subject_name: SEVELAMER


subject: UNII:9YCX42I8IU

subject_name: sevelamer carbonate


subject: CHEBI:31348

subject_name: Capecitabine

object_name: esophageal adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: gallbladder carcinoma


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174

object_name: cholangiocarcinoma


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601

object_name: gastric adenocarcinoma


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UNII:234248D0HH

subject_name: Tucatinib


subject: UNII:234248D0HH


subject: UNII:234248D0HH

object_name: colorectal carcinoma


subject: UNII:234248D0HH


subject: UNII:234248D0HH


subject: UNII:234248D0HH


subject: MESH:C079198

subject_name: S 1 (combination)


subject: UMLS:C5963387

subject_name: Anti-TAA Monoclonal Antibody-chelator Conjugate BAY3547922

object_name: liver carcinoma


subject: UNII:6B7TYB2MJX

subject_name: Cudetaxestat

object_name: interstitial lung disease 1


subject: UNII:6B7TYB2MJX

object_name: interstitial lung disease 2


subject: UMLS:C5853745


subject: UMLS:C5853745


subject: CHEBI:85990

subject_name: Panobinostat

object_name: leukemia


subject: CHEBI:85990

object_name: childhood leukemia


subject: CHEBI:8802

subject_name: Remifentanil

object_name: cardiovascular disorder


subject: UNII:UG97LO5M8Y

subject_name: Tesetaxel


subject: UNII:UG97LO5M8Y


subject: CHEBI:78887

subject_name: Tirapazamine

object_name: neuroendocrine neoplasm


subject: CHEBI:78887

object_name: Gastrointestinal cancer metastatic


subject: CHEBI:78887


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Emergence Delirium


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: PUBCHEM.COMPOUND:77014446

subject_name: Ketofol


subject: CHEBI:77590

subject_name: Armodafinil

object_name: traumatic encephalopathy


subject: CHEBI:77590

object_name: traumatic brain injury


subject: CHEBI:4466

object_name: musculoskeletal system disorder


subject: UNII:7N8K34P2XH


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam


subject: CHEBI:151315

subject_name: Heparin

object_name: Catheter related infection


subject: CHEBI:151315

object_name: Catheter infection


subject: CHEBI:151315

object_name: Catheter related complication


subject: CHEBI:151315

object_name: dialysis catheter; thrombosis


subject: CHEBI:151315

object_name: Catheter blockage


subject: CHEBI:151315

object_name: Catheter dysfunction


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374


subject: CHEBI:32139


subject: CHEBI:32139


subject: CHEBI:32139


subject: CHEBI:32139


subject: CHEBI:32139


subject: CHEBI:32139


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Anterior Cruciate Ligament Tear


subject: PUBCHEM.COMPOUND:21982135


subject: CHEBI:73038

subject_name: Parecoxib


subject: CHEBI:63634

subject_name: Valdecoxib


subject: CHEBI:6339

subject_name: Etoricoxib


subject: CHEBI:41879

object_name: proliferative diabetic retinopathy


subject: UMLS:C5908053

subject_name: Anti-CD47/CD20 Bispecific Antibody CC-96673

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5908053

object_name: non-Hodgkin lymphoma


subject: CHEBI:74224

object_name: Childhood Breast Carcinoma


subject: CHEBI:74224

object_name: breast carcinoma


subject: CHEBI:74224

object_name: breast cancer


subject: CHEBI:27514

subject_name: genistin


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:28088

subject_name: Genistein


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:52717

object_name: childhood myelodysplastic syndrome


subject: CHEBI:52717

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:52717

object_name: leukemia


subject: CHEBI:52717

object_name: childhood leukemia


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:94708

subject_name: Diacerein


subject: CHEMBL.COMPOUND:CHEMBL2108703

subject_name: LIPROTAMASE

object_name: exocrine pancreatic insufficiency


subject: CHEMBL.COMPOUND:CHEMBL2108703

object_name: cystic fibrosis


subject: UMLS:C4733884

subject_name: Liprotamase


subject: UMLS:C4733884


subject: UMLS:C4473674

subject_name: Nicotinamide Tablet

object_name: glaucoma


subject: UMLS:C4473674

object_name: Glaucoma, CTCAE


subject: CHEBI:6801

subject_name: Metformin

object_name: Weight Gain


subject: CHEBI:6801

object_name: Weight Gain, CTCAE


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: periapical periodontitis


subject: CHEBI:7421

subject_name: NAC


subject: CHEMBL.COMPOUND:CHEMBL2108237

subject_name: CAPSICUM OLEORESIN

object_name: Cough


subject: CHEMBL.COMPOUND:CHEMBL2108237

object_name: Cough, CTCAE


subject: CHEBI:94366

subject_name: itraconazole

object_name: Mycoses


subject: CHEBI:8382

subject_name: Prednisone

object_name: Philadelphia Chromosome


subject: CHEBI:8382

object_name: Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: CHEBI:8382

object_name: IKZF1 Gene Mutation


subject: CHEBI:8382

object_name: adult acute lymphoblastic leukemia


subject: UNII:KV1M7Q3CBP


subject: UNII:KV1M7Q3CBP


subject: UNII:KV1M7Q3CBP


subject: UNII:KV1M7Q3CBP


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab


subject: UNII:4FR53SIF3A


subject: UNII:4FR53SIF3A


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: acute lymphoblastic leukemia


subject: CHEBI:135918


subject: CHEBI:135918


subject: CHEBI:135918


subject: CHEBI:135918


subject: UMLS:C5400018

subject_name: Defibrotide, Pig

object_name: plasma cell myeloma


subject: UNII:438HCF2X0M

subject_name: Defibrotide


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Clostridium difficile colitis


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:74947

subject_name: Thalidomide

object_name: gastric antral vascular ectasia


subject: CHEBI:74947

object_name: liver cirrhosis


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: Mantle cell lymphoma refractory


subject: MESH:D003069

subject_name: Coffee

object_name: body weight


subject: UMLS:C1704263

subject_name: green tea extract


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: UMLS:C0729000

subject_name: Transamin

object_name: head and neck neoplasm


subject: UMLS:C4723695

subject_name: penpulimab

object_name: Hodgkin Disease


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Palmar hyperhidrosis


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:41879

subject_name: Dexamethasone


subject: PUBCHEM.COMPOUND:3080646

subject_name: Librax


subject: RXCUI:28697


subject: PUBCHEM.COMPOUND:9916099

subject_name: Letermovir

object_name: cytomegalovirus infection


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: diabetic kidney disease


subject: CHEBI:8228

object_name: inherited lipid metabolism disorder


subject: CHEBI:8228

object_name: Dyslipidemia


subject: RXCUI:2648470

subject_name: mometasone furoate Nasal Spray

object_name: Atopic rhinitis


subject: RXCUI:2648470

object_name: Hay fever


subject: CHEBI:5775

subject_name: Hydralazine

object_name: Acute Stroke


subject: CHEBI:5775

object_name: Acute Stroke Related to COVID-19


subject: CHEBI:167638

subject_name: Labetalol


subject: CHEBI:167638


subject: CHEBI:180905

subject_name: Nicardipine


subject: CHEBI:180905


subject: UMLS:C3248394

subject_name: Injection, ipilimumab, 1 mg administered

object_name: skin melanoma


subject: UMLS:C5203457

subject_name: Ipilimumab Liquid Injection


subject: PUBCHEM.COMPOUND:152165

object_name: osteoarthritis of multiple joints of ankle or foot


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:75722

subject_name: Tramadol


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: Advanced Hepatocellular Carcinoma


subject: GTOPDB:12966

object_name: biliary tract cancer


subject: GTOPDB:12966

object_name: Refractory Hepatocellular Carcinoma


subject: GTOPDB:12966

object_name: liver carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C4727210


subject: UMLS:C4727210


subject: GTOPDB:13887

subject_name: ligufalimab


subject: GTOPDB:13887


subject: GTOPDB:13887


subject: GTOPDB:13887


subject: UNII:1S4338NZB8

subject_name: LIGUFALIMAB


subject: UNII:1S4338NZB8


subject: UNII:1S4338NZB8


subject: UNII:1S4338NZB8


subject: UMLS:C5447482

subject_name: Ligufalimab


subject: UMLS:C5447482


subject: UMLS:C5447482


subject: UMLS:C5447482


subject: PUBCHEM.COMPOUND:21874242

subject_name: Vinflunine

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:21874242

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:21874242

object_name: breast cancer


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: oral cavity squamous cell carcinoma


subject: UMLS:C1948073


subject: CHEBI:27732

subject_name: Caffeine

object_name: apnea of prematurity


subject: UMLS:C4726564

subject_name: RV001 Vaccine

object_name: prostate carcinoma


subject: UMLS:C4726564

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:2269

object_name: Peptic Ulcer


subject: PUBCHEM.COMPOUND:2269

object_name: dyspepsia


subject: PUBCHEM.COMPOUND:2269

object_name: Dyspepsia, CTCAE


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:2955


subject: UMLS:C1831874

object_name: plasma cell myeloma


subject: CHEBI:63630

subject_name: Tolcapone

object_name: alcohol abuse


subject: CHEBI:63630

object_name: alcohol dependence


subject: CHEBI:63630

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:63630


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: severe acute respiratory syndrome


subject: CHEBI:5801

object_name: acute respiratory distress syndrome


subject: CHEBI:5801

object_name: adult acute respiratory distress syndrome


subject: UMLS:C0939788

subject_name: Zometa


subject: UMLS:C0939788


subject: PUBCHEM.COMPOUND:91826462

subject_name: Sutent

object_name: malignant glioma


subject: PUBCHEM.COMPOUND:91826462

object_name: glioblastoma


subject: PUBCHEM.COMPOUND:91826462

object_name: Brain Stem Glioblastoma


subject: PUBCHEM.COMPOUND:91826462

object_name: glioma susceptibility 1


subject: CHEBI:38940

subject_name: Sunitinib


subject: MESH:C560745

object_name: Adult attention deficit hyperactivity disorder


subject: CHEBI:135905

subject_name: Terlipressin

object_name: liver cirrhosis


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Acquired trigger finger


subject: CHEBI:150712

object_name: trigger thumb


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Non-small cell lung cancer stage I


subject: CHEBI:31355

object_name: Non-small cell lung cancer stage II


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: Angina pectoris


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: CHEBI:59173

subject_name: Bivalirudin


subject: CHEBI:6121

subject_name: Ketamine

object_name: Caries of infancy


subject: UMLS:C1328728

object_name: mycosis fungoides


subject: UMLS:C1328728

object_name: Sezary syndrome


subject: UNII:6O85FK9I0X

subject_name: Vatiquinone

object_name: inborn mitochondrial metabolism disorder


subject: UNII:6O85FK9I0X

object_name: mitochondrial disease


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: cancer


subject: CHEBI:64073

object_name: Prediabetes


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin


subject: CHEBI:40237

subject_name: Sitagliptin


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Alzheimer disease type 1


subject: UNII:4Z63YK6E0E

object_name: Alzheimer disease


subject: MESH:C000730795

object_name: Myocardial injury